Walleye Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,200
Closed -$64K 2073
2019
Q4
$64K Buy
+10,200
New +$60K ﹤0.01% 1470
2019
Q3
Sell
-10,600
Closed -$49K 2466
2019
Q2
$49K Buy
10,600
+500
+5% +$2.33K 0.01% 1390
2019
Q1
$54K Buy
+10,100
New +$46.1K 0.01% 1190

Other funds holding BDSI

Walleye Capital's BDSI Position: Q1 2020 in Review

Walleye Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 1,500 shares — an estimated $10K sold.

Walleye Capital first reported a position in BDSI in Q1 2019 and held it in 2 quarters. The position peaked at $12K in Q1 2019. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.

  • Walleye Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 1,500 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $10K.
  • Walleye Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2019 and held it in 2 quarters.
  • Walleye Capital's BioDelivery Sciences International, Inc. position peaked at $12K in Q1 2019.
  • 153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.